PRQR
1.87 USD
-6.19%
Today
-6.19%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 11:00 PM
Tue
4:30 PM ~ 11:00 PM
Wed
4:30 PM ~ 11:00 PM
Thu
4:30 PM ~ 11:00 PM
Fri
4:30 PM ~ 11:00 PM
Sat
Closed
Information
Name
ProQR Therapeutics Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0191%
Overnight Fees Sell
0.0024%
Market Cap
180.17M
Avg Daily Volume
495.34K
52 Week High
3.1 USD
52 Week Low
1.07 USD
Trading Hours
See hours
Overnight Fees Calculator
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01910% | $(0.191) |
| SELLS | 0.00240% | $0.024 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Business Summary
ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops an RNA editing platform through its Axiomer RNA editing technology for genetic disorders with unmet needs. Its lead product candidate, AX-0810, targets na-taurocholate cotransporting polypeptide (NTCP) for the treatment of cholestatic diseases. The company also develops AX-2402, which targets methyl CpG binding protein 2 mutations for Rett syndrome; AX-2911, which targets PNPLA3 for metabolic dysfunction-associated steatohepatitis; and AX-1412, which targets the B4GALT1 gene for cardiovascular diseases. It has a research and collaboration agreement with Eli Lilly and Company for the discovery, development, and commercialization of potential new medicines for genetic disorders in the liver and nervous system. The company was incorporated in 2012 and is headquartered in Leiden, the Netherlands.
Top News
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event
tradingview.com
3d ago
AmAirlines
-0.53%
AbbottLabs
-2.35%
Aehr.Systems
+1.44%
AmgenInc
+0.94%
Amarin
-0.91%
Apollo
-2.49%
AxonEnterprise
-1.56%
BOAmerica
-0.13%
Beyond.Inc
-1.68%
BookingHld
-1.76%
BioXcel
-0.95%
Blackstone
-1.66%
Coeur
+2.59%
CFIndustries
+1.73%
Chegg
-6.02%
Chewy
-2.86%
Clean.Spark
-2.25%
Coinbase
-1.15%
Chevron
-0.53%
Delta
-0.16%
Deere
-1.20%
DR_Horton
+0.35%
Devon
+0.23%
ElancoAnimal
-1.50%
Elevance-Health-Inc
-2.02%
Expedia
-1.01%
Freeport_Mcmoran
+2.43%
GATX_Corp
+1.37%
Greenbrier
-2.34%
GileadSci
-2.26%
GoldmanSachs
+0.80%
HimsandHers.Inc
-0.41%
Hecla.Mining
+0.73%
Humana
-2.52%
IDEXXLab
-3.76%
Insmed
-3.03%
JBHunt
+0.86%
JPMorgan
+0.09%
KKR&Co
-1.65%
Lennar
+0.51%
Levi.Strauss
+0.00%
Southwest
-1.74%
Mosaic
-2.06%
MicroStrategy
-0.76%
NorwegianCruise
+1.06%
NewmontM
+2.35%
Novavax
-5.52%
Opko
-1.74%
Occidental
+0.00%
PulteGroup
-1.54%
ProQR.Therapeutics
-6.19%
SouthernCopper
+2.32%
Scorpio.Tankers
-2.29%
TollBrothers
-0.04%
UnitySoftware
+0.33%
UnitedCon
-1.32%
UnitedHlt
-0.66%
ViaSat
+0.92%
Westinghouse
-1.21%
WellsFargo
-0.61%
ExxonMobil
-1.24%
ZoetisInc
-1.82%
BUZZ-U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
reuters.com
3d ago
ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board
tradingview.com
3d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
